Charité — Universitätsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program

Charité — Universitätsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program Leading oncology research hospital becomes new member to advance Oncomine™ liquid biopsy and immuno-oncology diagnostics BERLIN and CARLSBAD, Calif., March 15, 2018 /PRNewswire/ — Thermo Fisher Scientific has named Charité – Universitätsmedizin Berlin as the newest member of its Next Generation Sequencing... Read more

Edico Genome Announces Flagship Global Distribution Partnership Program

SAN DIEGO — March 13, 2018 – Edico Genome, the leading secondary analysis solution provider for next-generation sequencing (NGS), today unveiled its DRAGENTM Global Distribution Partner Network, a new program broadening access to its DRAGEN Bio-IT Platform to markets around the world. The Global Distribution Partner Network will provide new and existing DRAGEN customers with regionally focused... Read more

Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing

MENLO PARK, Calif., March 13, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 9,910,956 (the “956 Patent”), entitled “Sequencing using concatemers of copies of sense and antisense strands.” The 956 Patent was... Read more

Illumina Names Dr. Phil Febbo Chief Medical Officer

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be responsible for developing and executing on the Company’s medical strategy to drive genomic testing into healthcare practice. “We are very excited to welcome... Read more

QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN’s GeneReader NGS System

Hilden, Germany, and San Carlos, CA, March 12, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of next-generation sequencing (NGS) assays that include non-invasive prenatal genetic testing and the analysis of circulating tumor DNA, today... Read more

QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN’s GeneReader NGS System

MAR 12 2018 Hilden, Germany, and San Carlos, CA, March 12, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of next-generation sequencing (NGS) assays that include non-invasive prenatal genetic testing and the analysis of circulating tumor... Read more

Pacific Biosciences Enhances Performance and Affordability of Key Applications on the Sequel System

MENLO PARK, Calif., March 07, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a new version of Sequel® Software (V5.1) and a new polymerase. Combined, these enhancements increase throughput and the overall performance of Single Molecule, Real-Time (SMRT®) Sequencing for key applications such as de... Read more

WuXi NextCODE Unveils Genomics Partnership with Google Cloud

– WuXi NextCODE’s massively scalable genomics database management system and clinical and research applications will be available to Google Cloud Platform users – Google Cloud BigQuery, the open source DeepVariant and other tools will be integrated for use with the WuXi NextCODE platform – The companies plan to work on additional tools, capabilities and APIs... Read more